TABLE 1.

Summary of clinical data from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial

	Clopidogrel (n=6259)	Placebo (n=6303)	P
Baseline characteristics
Age, years (mean ± SD)	64±11	64±11	0.7448
Female sex, %	39	38	0.6450
Myocardial infarction at presentation, %	26	26	0.6098
Prior myocardial infarction, %	32	32	0.6314
Diabetes, %	22	23	0.5920
Hypertension, %	60	58	0.0168
Clinical outcomes in economic study, %	9.3	11.4	<0.0001
Death (any cause)	5.8	6.2	0.2779
Myocardial infarction	5.2	6.7	0.0004
Stroke	1.2	1.4	0.3532
Bleeding, major or life threatening, %	3.7	2.7	0.0015
Major	1.5	0.9	0.0020
Life-threatening	2.1	1.7	0.1000
Major and life-threatening	0.1	0.1	0.9999
Minor bleeding, %	5.1	2.4	<0.0001